Economic aspects of complicated osteoporosis: The cost of treatment in the first year after fracture
Objective: to estimate the cost of treatment in patients with complicated osteoporosis (OP) in the first year after fracture under the conditions of the Moscow municipal healthcare system.Patients and methods. The investigation enrolled 196 women (mean age, 65.8±9.1 years) who had sustained fracture...
Main Authors: | O. V. Dobrovolskaya, N. V. Toroptsova, O. M. Lesnyak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-09-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/698 |
Similar Items
-
Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01) -
Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01) -
The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
by: Olga Mikhailovna Lesnyak
Published: (2013-10-01) -
Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
by: N. V. Toroptsova
Published: (2018-12-01) -
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
by: Irina Aleksandrovna Baranova
Published: (2010-06-01)